TNF-α shedding was significantly inhibited in the infliximab group compared to the vehicle, but surprisingly infliximab did not inhibit tumour growth, in contrast to the published study showing that TNF-α shRNA knockdown did inhibit IGROV1-Luc tumour growth in vivo[37]. This evidence concerns the gene TNF and neoplasm.